Atypical cholangiocytes derived from hepatocyte-cholangiocyte transdifferentiation mediated by COX-2: a kind of misguided liver regeneration
Open Access
- 14 July 2023
- journal article
- research article
- Published by Springer Nature in Inflammation and Regeneration
- Vol. 43 (1) , 1-13
Abstract
Background: Hepatocyte-cholangiocyte transdifferentiation (HCT) is a potential origin of proliferating cholangiocytes in liver regeneration after chronic injury. This study aimed to determine HCT after chronic liver injury, verify the impacts of HCT on liver repair, and avoid harmful regeneration by understanding the mechanism. Methods: A thioacetamide (TAA)-induced liver injury model was established in wild-type (WT-TAA group) and COX-2 panknockout (KO-TAA group) mice. HCT was identified by costaining of hepatocyte and cholangiocyte markers in vivo and in isolated mouse hepatocytes in vitro. The biliary tract was injected with ink and visualized by whole liver optical clearing. Serum and liver bile acid (BA) concentrations were measured. Either a COX-2 selective inhibitor or a β-catenin pathway inhibitor was administered in vitro. Results: Intrahepatic ductular reaction was associated with COX-2 upregulation in chronic liver injury. Immunofluorescence and RNA sequencing indicated that atypical cholangiocytes were characterized by an intermediate genetic phenotype between hepatocytes and cholangiocytes and might be derived from hepatocytes. The structure of the biliary system was impaired, and BA metabolism was dysregulated by HCT, which was mediated by the TGF-β/β-catenin signaling pathway. Genetic deletion or pharmaceutical inhibition of COX-2 significantly reduced HCT in vivo. The COX-2 selective inhibitor etoricoxib suppressed HCT through the TGF-β-TGFBR1-β-catenin pathway in vitro. Conclusions: Atypical cholangiocytes can be derived from HCT, which forms a secondary strike by maldevelopment of the bile drainage system and BA homeostasis disequilibrium during chronic liver injury. Inhibition of COX-2 could ameliorate HCT through the COX-2-TGF-β-TGFBR1-β-catenin pathway and improve liver function.Keywords
Funding Information
- the National Natural Science Fund of China (82170625, 82170623, 82000613, 82200687, 82241054)
- the 135 projects for disciplines of excellence of West China Hospital, Sichuan University (ZYGD18004)
This publication has 30 references indexed in Scilit:
- Hippo Pathway Activity Influences Liver Cell FateCell, 2014
- The Liver Is a Peculiar Organ When It Comes to Stem CellsThe American Journal of Pathology, 2014
- Hepatocytes, Rather than Cholangiocytes, Can Be the Major Source of Primitive Ductules in the Chronically Injured Mouse LiverThe American Journal of Pathology, 2014
- Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and AngiogenesisPLOS ONE, 2013
- Robust cellular reprogramming occurs spontaneously during liver regenerationGenes & Development, 2013
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Disparate Cellular Basis of Improved Liver Repair in β-Catenin-Overexpressing Mice After Long-Term Exposure to 3,5-Diethoxycarbonyl-1,4-DihydrocollidineThe American Journal of Pathology, 2010
- Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and RegenerationCell, 2009
- Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in ratsGut, 2009
- Control of liver cell fate decision by a gradient of TGFβ signaling modulated by Onecut transcription factorsGenes & Development, 2005